Navigating Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory - Episode 15
Future Treatment Considerations for Multiple Myeloma
Panelists discuss how they approach sequencing therapy for relapsed/refractory multiple myeloma, considering all approved and investigational agents, and the factors that guide their treatment choices. They also explore the future directions of the later-stage relapsed/refractory multiple myeloma space, time permitting.
Video content above is prompted by the following:
- Considering all the agents (approved and in development), how do you approach sequencing therapy?
- How would you choose? What are the factors you consider?
- Where is the later-stage R/R MM space headed (time permitting)?
Related Content:
